Taro Pharmaceutical Industries Ltd. (NYSE:TARO) continued to lead the category in 2013 with a retail value share of 25% thanks to brands such as Tarodent and Anadent, which held shares of 22% and 3%, respectively. Taro Pharmaceutical Industries Ltd. (NYSE:TARO) stock performance was 16.65% in last session and finished the day at $137.97. Traded volume was 227,446.00million shares in the last session and the average … Continue reading Healthcare Touched New Highs: Taro Pharmaceutical Industries (NYSE:TARO), Inogen (NASDAQ:INGN), Health Net (NYSE:HNT)